Lataa...
Mechanisms of resistance to osimertinib
The introduction of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) has significantly improved the prognosis of advanced non-small cell lung cancer (NSCLC) patients with EGFR mutations. The most common mechanism of acquired resistance to first- and second-generation EGFR TKIs...
Tallennettuna:
| Julkaisussa: | J Thorac Dis |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330330/ https://ncbi.nlm.nih.gov/pubmed/32642198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.08.30 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|